EMA, FDA be­gin re­view­ing heart­burn med­i­cines for car­cino­gen

Fol­low­ing its in­ves­ti­ga­tion in­to an im­pu­ri­ty called N-ni­troso­di­methy­lamine (ND­MA) in blood pres­sure med­i­cines, the EMA on Fri­day said that, at the re­quest of the Eu­ro­pean …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER